Detalhe da pesquisa
1.
A phase III randomized controlled trial comparing local field with additional prophylactic irradiation in chemoradiotherapy for clinical-T1bN0M0 esophageal cancer: ARMADILLO trial (JCOG1904).
Jpn J Clin Oncol
; 54(1): 103-107, 2024 Jan 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37801434
2.
Exploratory analysis of serum HER2 extracellular domain for HER2 positive gastric cancer treated with SOX plus trastuzumab.
Int J Clin Oncol
; 29(6): 801-812, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38589679
3.
Outcomes of definitive carbon-ion radiotherapy for cT1bN0M0 esophageal squamous cell carcinoma.
Esophagus
; 2024 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38814482
4.
Remarkable response as a new indicator for endoscopic evaluation of local efficacy of non-surgical treatments for esophageal cancer.
Esophagus
; 21(2): 85-94, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38353829
5.
Mutational spectrum of TP53 gene correlates with nivolumab treatment efficacy in advanced gastric cancer (TP53MUT study).
Br J Cancer
; 129(6): 1032-1039, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37532830
6.
Clinical factors associated with noncurative endoscopic submucosal dissection for the expanded indication of intestinal-type early gastric cancer: Post hoc analysis of a multi-institutional, single-arm, confirmatory trial (JCOG0607).
Dig Endosc
; 35(4): 494-502, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36286956
7.
Concurrent chemoradiotherapy using proton beams can reduce cardiopulmonary morbidity in esophageal cancer patients: a systematic review.
Esophagus
; 20(4): 605-616, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37328706
8.
Phase IIb study of pembrolizumab combined with S-1 + oxaliplatin or S-1 + cisplatin as first-line chemotherapy for gastric cancer.
Cancer Sci
; 113(8): 2814-2827, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35701865
9.
An exploration of trifluridine/tipiracil in combination with irinotecan in patients with pretreated advanced gastric cancer.
Invest New Drugs
; 40(3): 614-621, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35278170
10.
Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study.
Gastric Cancer
; 25(1): 207-217, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34480657
11.
Effect of chemoradiation on the development of second primary cancers after endoscopic resection of T1 esophageal squamous cell carcinoma.
Esophagus
; 19(3): 469-476, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35320430
12.
A nonrandomized, single-arm confirmatory trial of expanded endoscopic submucosal dissection indication for undifferentiated early gastric cancer: Japan Clinical Oncology Group study (JCOG1009/1010).
Gastric Cancer
; 24(2): 479-491, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33161444
13.
Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab.
Gastric Cancer
; 24(4): 946-958, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33743112
14.
Cancer-related FGFR2 overexpression and gene amplification in Japanese patients with gastric cancer.
Jpn J Clin Oncol
; 51(10): 1523-1533, 2021 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34258618
15.
Diagnostic yield of conventional endoscopy with endoscopic ultrasonography for submucosal invasion of superficial esophageal squamous cell carcinoma: a post hoc analysis of multicenter prospective confirmatory study (JCOG0508).
Esophagus
; 18(3): 604-611, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33506366
16.
Five-year follow-up of nivolumab treatment in Japanese patients with esophageal squamous-cell carcinoma (ATTRACTION-1/ONO-4538-07).
Esophagus
; 18(4): 835-843, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33993388
17.
Long-term efficacy and predictive correlates of response to nivolumab in Japanese patients with esophageal cancer.
Cancer Sci
; 111(5): 1676-1684, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32160365
18.
Efficacy of Endoscopic Resection and Selective Chemoradiotherapy for Stage I Esophageal Squamous Cell Carcinoma.
Gastroenterology
; 157(2): 382-390.e3, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31014996
19.
Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer.
Gastric Cancer
; 23(1): 143-153, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31087200
20.
A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data.
Gastric Cancer
; 23(3): 510-519, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31863227